loadpatents
Patent applications and USPTO patent grants for Meetze; Kristan.The latest application filed is for "glycan-interacting compounds and methods of use".
Patent | Date |
---|---|
Glycan-Interacting Compounds and Methods of Use App 20220057402 - da Silva; Ana Paula Galvao ;   et al. | 2022-02-24 |
Glycan-Interacting Compounds and Methods of Use App 20210011021 - da Silva; Ana Paula Galvao ;   et al. | 2021-01-14 |
Anti-erbb3 Antibodies App 20200299406 - Vincent; Sylvie ;   et al. | 2020-09-24 |
Glycan-Interacting Compounds and Methods of Use App 20200276306 - da Silva; Ana Paula Galvao ;   et al. | 2020-09-03 |
Anti-ERBB3 antibodies Grant 10,494,441 - Vincent , et al. De | 2019-12-03 |
Platinum compounds, compositions, and uses thereof Grant 10,322,137 - Bilodeau , et al. | 2019-06-18 |
Glycan-interacting Compounds And Methods Of Use App 20180280504 - da Silva; Ana Paula Galvao ;   et al. | 2018-10-04 |
Predicting Tumor Response To Anti-erbb3 Antibodies App 20180195120 - Vincent; Sylvie ;   et al. | 2018-07-12 |
Platinum compounds, compositions, and uses thereof Grant 9,937,187 - Bilodeau , et al. April 10, 2 | 2018-04-10 |
Anti-erbb3 Antibodies App 20180030149 - Vincent; Sylvie ;   et al. | 2018-02-01 |
Platinum Compounds, Compositions, And Uses Thereof App 20180008614 - Bilodeau; Mark T. ;   et al. | 2018-01-11 |
Predicting tumor response to anti-ERBB3 antibodies Grant 9,828,635 - Vincent , et al. November 28, 2 | 2017-11-28 |
Glycan-interacting Compounds And Methods Of Use App 20170306046 - daSilva; Ana Paula Galvao ;   et al. | 2017-10-26 |
Anti-erbb3 Antibodies App 20160264679 - Vincent; Sylvie ;   et al. | 2016-09-15 |
Anti-ErbB3 antibodies Grant 9,228,021 - Vincent , et al. January 5, 2 | 2016-01-05 |
Anti-ron antibodies Grant 8,829,164 - Whalen , et al. September 9, 2 | 2014-09-09 |
Predicting Tumor Response To Anti-erbb3 Antibodies App 20140242597 - Vincent; Sylvie ;   et al. | 2014-08-28 |
Anti-ron Antibodies App 20140066603 - Whalen; Kerry ;   et al. | 2014-03-06 |
Anti-erbb3 Antibodies App 20130330772 - Vincent; Sylvie ;   et al. | 2013-12-12 |
Anti-RON antibodies Grant 8,603,478 - Whalen , et al. December 10, 2 | 2013-12-10 |
Anti-fgfr2 Antibodies App 20130288305 - Weng; Zhigang ;   et al. | 2013-10-31 |
Anti-FGFR2 antibodies Grant 8,481,688 - Weng , et al. July 9, 2 | 2013-07-09 |
Anti-ErbB3 antibodies Grant 8,481,687 - Vincent , et al. July 9, 2 | 2013-07-09 |
Fibroblast growth factor receptor 3 (FGFR3) binding proteins Grant 8,187,601 - Weng , et al. May 29, 2 | 2012-05-29 |
Anti-ron Antibodies App 20120027773 - Whalen; Kerry ;   et al. | 2012-02-02 |
Anti-fgfr2 Antibodies App 20110305687 - Weng; Zhigang ;   et al. | 2011-12-15 |
Anti-erbb3 Antibodies App 20110256154 - Vincent; Sylvie ;   et al. | 2011-10-20 |
Fibroblast Growth Factor Receptor 3 (fgfr3) Binding Proteins App 20100003258 - Weng; Zhigang ;   et al. | 2010-01-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.